USA Compression Partners, LP USAC
25.54
0.01
0.04%
as of 25 Sep
- Market cap
- $3.7B
- P/E
- 23.9×
Follow USAC
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
29.63 | 27.06 | 27.67 | 24.66 |
P/S ratio |
2.97 | 2.78 | 3.57 | 3.25 | |
P/FCF ratio |
10.06 | 9.95 | 12.69 | 12.24 | |
P/Operating CF |
38.80 | 19.91 | 44.96 | 26.26 | |
P/B ratio |
0.00 | 0.00 | 12.23 | 13.33 | |
Price to Tangible BV |
0.00 | 0.00 | 263.83 | 0.00 | |
EV/Sales |
5.52 | 5.30 | 6.31 | 5.75 | |
EV/EBITDA |
9.08 | 8.71 | 10.58 | 9.92 | |
EV/Operating CF |
14.22 | 13.42 | 16.06 | 15.11 | |
EV/FCF |
18.70 | 18.95 | 22.40 | 21.63 | |
Quick Ratio |
0.55 | 0.48 | 0.74 | 0.59 | |
Current Ratio |
1.36 | 1.27 | 1.55 | 1.35 | |
Net Debt/EBITDA |
16.02 | 16.64 | 16.42 | 15.30 | |
Debt/Assets |
95.12% | 96.34% | 79.81% | 79.83% | |
Debt/Equity |
(32.93) | (22.43) | 9.41 | 10.25 | |
Asset Turnover |
0.36 | 0.37 | 0.34 | 0.37 | |
Operating CF/Net income |
2.33 | 5.02 | 2.25 | 3.19 | |
Capex/Depreciation |
(0.32) | (0.69) | (0.26) | (0.40) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.67% | 7.09% | 10.67% | 8.45% | |
Intangible Assets out of Total Assets |
0.07 | 0.07 | 0.08 | 0.08 | |
Share Based Compensation of Revenue |
0.47% | 0.60% | 0.73% | 0.47% | |
Graham Net Nets |
(0.84) | (0.90) | (0.79) | (0.80) | |
Graham Number |
0.00 | 0.00 | 6.99 | 6.90 | |
Earnings Yield |
3.38% | 3.70% | 3.61% | 4.05% | |
Free Cash Flow Yield |
9.94% | 10.05% | 7.88% | 8.17% | |
Revenue per Share |
2.04 | 2.09 | 2.32 | 2.36 | |
Operating CF per Share |
0.62 | 1.16 | 0.60 | 1.00 | |
Capex per Share |
(0.19) | (0.42) | (0.17) | (0.25) | |
Free Cash Flow per Share |
0.43 | 0.73 | 0.44 | 0.75 | |
Cash per Share |
0.00 | 0.07 | 0.10 | 0.07 | |
Shareholders Equity per Share |
(0.63) | (0.93) | 2.22 | 1.98 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.63) | (0.93) | 2.22 | 1.98 | |
Free Cash Flow |
52.50 | 88.31 | 62.48 | 109.25 | |
Working Capital |
66.79 | 49.66 | 122.60 | 82.91 | |
Capital Expenditures |
(23.38) | (51.18) | (23.63) | (36.44) | |
Net Current Asset Value |
(2,484.45) | (2,495.86) | (3,070.93) | (3,075.42) | |
EV/EBIT |
17.98 | 17.27 | 20.81 | 19.18 | |
Capex to Sales |
0.09 | 0.20 | 0.07 | 0.11 | |
Net Profit Margin |
13.00% | 10.99% | 11.57% | 13.34% | |
Price to Operating Income |
9.67 | 9.06 | 11.78 | 10.86 | |
| Other line items | |||||
Average Receivables |
99.99 | 84.65 | 123.18 | 112.12 | |
Average Payables |
28.15 | 23.68 | 34.84 | 32.71 | |
Average Inventory |
142.09 | 134.19 | 144.35 | 147.48 | |
Average Assets |
2,731.42 | 2,682.77 | 3,223.78 | 3,178.43 | |
Average Common Equity |
(128.73) | (126.78) | 67.98 | 82.83 |
Columns are period end dates